Abstract
Abstract Background B-cell maturation antigen (BCMA)–directed chimeric antigen receptor (CAR) T-cell therapies have generated responses in patients with advanced myeloma, but relapses are common. G...
Cite
CITATION STYLE
APA
Mailankody, S., Devlin, S. M., Landa, J., Nath, K., Diamonte, C., Carstens, E. J., … Smith, E. L. (2022). GPRC5D-Targeted CAR T Cells for Myeloma. New England Journal of Medicine, 387(13), 1196–1206. https://doi.org/10.1056/nejmoa2209900
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free